Metropolis Healthcare Limited

NSEI:METROPOLIS 주식 보고서

시가총액: ₹103.6b

Metropolis Healthcare 과거 수익 실적

과거 기준 확인 2/6

Metropolis Healthcare의 수입은 연평균 -1.5%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 23.2%의 비율로 증가했습니다. 매출은 연평균 8.1%의 비율로 증가해 왔습니다. Metropolis Healthcare의 자기자본이익률은 12.5%이고 순이익률은 11.5%입니다.

주요 정보

-1.5%

수익 성장률

-1.9%

EPS 성장률

Healthcare 산업 성장29.4%
매출 성장률8.1%
자기자본 수익률12.5%
순이익11.5%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 13
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

수익 및 비용 분석

Metropolis Healthcare 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NSEI:METROPOLIS 수익, 비용 및 수입 (INR Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 2412,8531,4804,291141
30 Jun 2412,4401,3704,204138
31 Mar 2412,0771,2784,138136
31 Dec 2311,5931,2483,88977
30 Sep 2311,5361,3343,84075
30 Jun 2311,4541,3833,75863
31 Mar 2311,4821,4293,73066
31 Dec 2211,7161,4953,80677
30 Sep 2211,7921,5483,78578
30 Jun 2211,8141,7273,68876
31 Mar 2212,2832,1423,64969
31 Dec 2112,1422,3552,99571
30 Sep 2111,9592,5312,89960
30 Jun 2111,8162,5512,86554
31 Mar 219,9801,8312,74654
31 Dec 209,1321,3722,59064
30 Sep 208,6131,2072,54567
30 Jun 207,9621,0341,89073
31 Mar 208,5641,2732,56769
31 Dec 198,5131,4632,60160
30 Sep 198,1891,3552,56360
30 Jun 197,8871,2302,54457
31 Mar 197,6121,2012,48656
31 Mar 186,4721,0422,00857
31 Mar 175,4471,0171,65825
31 Mar 164,7557681,38831
31 Mar 154,5556101,18137
31 Mar 143,88356693235

양질의 수익: METROPOLIS 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: METROPOLIS 의 현재 순이익 이익률 (11.5%) 작년보다 낮습니다 (11.6%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: METROPOLIS 의 수입은 지난 5년 동안 매년 1.5% 씩 감소했습니다.

성장 가속화: 지난 1년간 METROPOLIS 의 수익 증가율( 11% )은 연간 평균( -1.5% 초과합니다. ).

수익 대 산업: 지난 1년간 METROPOLIS 수익 성장( 11% )은 Healthcare 업계 33.2% 능가하지 못했습니다. 33.2%.


자기자본 수익률

높은 ROE: METROPOLIS 의 자본 수익률( 12.5% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기